IMARC Research Competitors and Similar CompaniesClear all

IMARC Research's competitors and similar companies include Adviqual, Factory CRO, Aix Scientifics and EastHORN.
IMARC Research
IMARC Research
IMARC Research is a medical device CRO specializing in patient protection and regulatory compliance for clinical research.
Adviqual
Adviqual
Adviqual is a medical device manufacturer.
Factory CRO
Factory CRO
Factory CRO is a contract research organization that specializes in medical device trials.
Aix Scientifics
Aix Scientifics
Aix Scientifics is a contract research organization that specializes in clinical research for new pharmaceutical products and medical devices.
EastHORN
EastHORN
EastHORN Clinical Services (also known as Novotech Clinical Research Poland) is a clinical research organization that specializes in phase I-IV studies.
Founding Date
Founding Date
1999
Founding Date
2015
Founding Date
1988
Founding Date
1996
Founding Date
2004
Type
Type
Subsidiary
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Strongsville, US HQ
Minnetonka, US
Locations
İstanbul, TR HQ
Locations
Bilthoven, NL HQ
Artarmon, AU
Collingwood, AU
Marlborough, US
San Diego, US
Strongsville, US
Locations
Aachen, DE HQ
Locations
Warszawa, PL HQ
Employees
Employees
19
Employees
9
Employees
814% increase
Employees
N/A
Employees
888% decrease
For sources of this data, please see the company profile

View Company Profiles

Adviqual
HQ
İstanbul, TR
Employees
9

Adviqual is a medical device manufacturer.

View company
Factory CRO
HQ
Bilthoven, NL
Employees
8↑ 14% increase

Factory CRO is a contract research organization that specializes in medical device trials.

View company
Aix Scientifics
HQ
Aachen, DE

Aix Scientifics is a contract research organization that specializes in clinical research for new pharmaceutical products and medical devices.

View company
EastHORN
HQ
Warszawa, PL

EastHORN Clinical Services (also known as Novotech Clinical Research Poland) is a clinical research organization that specializes in phase I-IV studies.

View company